Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis.

Suppr

超能文献

作者信息

Romano C, Comito D, Famiani A, Fries W

出版信息

Aliment Pharmacol Ther. 2010 Mar;31(6):676-7; author reply 677-8. doi: 10.1111/j.1365-2036.2009.04213.x.

DOI:10.1111/j.1365-2036.2009.04213.x

PMID:20148798

Abstract

摘要

相似文献

Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis.

Aliment Pharmacol Ther. 2010 Mar;31(6):676-7; author reply 677-8. doi: 10.1111/j.1365-2036.2009.04213.x.

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.

Aliment Pharmacol Ther. 2008 Sep 1;28(5):589-97. doi: 10.1111/j.1365-2036.2008.03764.x. Epub 2008 Jun 28.

Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children.

J Pediatr Gastroenterol Nutr. 2007 Sep;45(3):306-11. doi: 10.1097/MPG.0b013e31805b82e4.

Oral tacrolimus treatment of severe colitis in children.

J Pediatr. 2000 Dec;137(6):794-9. doi: 10.1067/mpd.2000.109193.

A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis.

Gut. 2006 Sep;55(9):1255-62. doi: 10.1136/gut.2005.081794. Epub 2006 Feb 16.

Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).

Am J Gastroenterol. 1998 Oct;93(10):1860-6. doi: 10.1111/j.1572-0241.1998.539_g.x.

The earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patients.

BMC Gastroenterol. 2015 Apr 29;15:53. doi: 10.1186/s12876-015-0285-3.

Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis.

World J Gastroenterol. 2015 Feb 14;21(6):1880-6. doi: 10.3748/wjg.v21.i6.1880.

Oral tacrolimus for pediatric steroid-resistant ulcerative colitis.

J Crohns Colitis. 2014 Jan;8(1):64-9. doi: 10.1016/j.crohns.2013.03.006. Epub 2013 Apr 9.

Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis.

Aliment Pharmacol Ther. 2003 Aug 15;18(4):415-23. doi: 10.1046/j.1365-2036.2003.01662.x.

引用本文的文献

The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.

J Gastroenterol. 2011 Feb;46(2):129-37. doi: 10.1007/s00535-010-0352-z. Epub 2010 Dec 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis.

Aliment Pharmacol Ther. 2010 Mar;31(6):676-7; author reply 677-8. doi: 10.1111/j.1365-2036.2009.04213.x.

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.

Aliment Pharmacol Ther. 2008 Sep 1;28(5):589-97. doi: 10.1111/j.1365-2036.2008.03764.x. Epub 2008 Jun 28.

Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children.

J Pediatr Gastroenterol Nutr. 2007 Sep;45(3):306-11. doi: 10.1097/MPG.0b013e31805b82e4.

Oral tacrolimus treatment of severe colitis in children.

J Pediatr. 2000 Dec;137(6):794-9. doi: 10.1067/mpd.2000.109193.

A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis.

Gut. 2006 Sep;55(9):1255-62. doi: 10.1136/gut.2005.081794. Epub 2006 Feb 16.

Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).

Am J Gastroenterol. 1998 Oct;93(10):1860-6. doi: 10.1111/j.1572-0241.1998.539_g.x.

The earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patients.

BMC Gastroenterol. 2015 Apr 29;15:53. doi: 10.1186/s12876-015-0285-3.

Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitis.

World J Gastroenterol. 2015 Feb 14;21(6):1880-6. doi: 10.3748/wjg.v21.i6.1880.

Oral tacrolimus for pediatric steroid-resistant ulcerative colitis.

J Crohns Colitis. 2014 Jan;8(1):64-9. doi: 10.1016/j.crohns.2013.03.006. Epub 2013 Apr 9.

Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis.

Aliment Pharmacol Ther. 2003 Aug 15;18(4):415-23. doi: 10.1046/j.1365-2036.2003.01662.x.

引用本文的文献

The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.

J Gastroenterol. 2011 Feb;46(2):129-37. doi: 10.1007/s00535-010-0352-z. Epub 2010 Dec 4.